© 2021 MJH Life Sciences and Contagion Live. All rights reserved.
© 2021 MJH Life Sciences™ and Contagion Live. All rights reserved.
August 22, 2021
What does this form of pre-exposure prophylaxis (PrEP) mean in terms of options and initiation.
August 19, 2021
HIV risk perception and concern regarding HIV infection declined during the study.
A review of selected investigational long-active treatment options for HIV.
August 18, 2021
Long acting injectable PrEP therapies that are safe and effective are needed to increase options for at-risk individuals.
Macro and micro strategies are at play in aiming to create greater PrEP access and adoption.
August 17, 2021
PrEP initiations, discontinuations and lapses all increased among Latinx patients post shelter-in-place orders.
August 16, 2021
A new study sought to approach the HIV epidemic in the United States through a distributional cost-effectiveness analysis across 6 cities.
August 10, 2021
An expert from Temple reflects on the first 10 years of PrEP innovation, and what's needed in the next decade.
August 09, 2021
Drugs, personnel, and laboratory costs comprised 50%, 38%, and 12% of program costs.
August 06, 2021
Some patients who switched appear to have done so in anticipation of clinical indications.